dc.creatorDhiman P.
dc.creatorMalik N.
dc.creatorSobarzo-Sánchez E.
dc.creatorUriarte E.
dc.creatorKhatkar A.
dc.date.accessioned2020-09-02T22:16:17Z
dc.date.accessioned2022-11-08T20:21:39Z
dc.date.available2020-09-02T22:16:17Z
dc.date.available2022-11-08T20:21:39Z
dc.date.created2020-09-02T22:16:17Z
dc.date.issued2019
dc.identifier24, 3, -
dc.identifier14203049
dc.identifierhttps://hdl.handle.net/20.500.12728/4265
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5144105
dc.languageen
dc.publisherMDPI AG
dc.subjectFlavonoids
dc.subjectIn-silico design
dc.subjectMental disorders
dc.subjectMonoamine oxidase
dc.subjectMonoamine oxidase inhibitors
dc.subjectNeurodegenerative disorder
dc.subjectQuercetin
dc.subjectflavonoid
dc.subjectmonoamine oxidase inhibitor
dc.subjectquercetin
dc.subjectanimal
dc.subjectchemical phenomena
dc.subjectchemistry
dc.subjecthuman
dc.subjectmental disease
dc.subjectmetabolism
dc.subjectmolecular model
dc.subjectneurologic disease
dc.subjectstructure activity relation
dc.subjectAnimals
dc.subjectChemical Phenomena
dc.subjectFlavonoids
dc.subjectHumans
dc.subjectMental Disorders
dc.subjectModels, Molecular
dc.subjectMonoamine Oxidase Inhibitors
dc.subjectNervous System Diseases
dc.subjectQuercetin
dc.subjectStructure-Activity Relationship
dc.titleQuercetin and related chromenone derivatives as monoamine oxidase inhibitors: Targeting neurological and mental disorders
dc.typeReview


Este ítem pertenece a la siguiente institución